Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

NCT01289899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: BR-A-657

Sponsor

Boryung Pharmaceutical Co., Ltd

Collaborators

[object Object]